401 related articles for article (PubMed ID: 17378791)
1. Early use of terlipressin in catecholamine-resistant shock improves cerebral perfusion pressure in severe traumatic brain injury.
Salluh JI; Martins GA; Santino MS; Araújo LV; Freitas GG; Verdeal JC
Acta Anaesthesiol Scand; 2007 Apr; 51(4):505-8. PubMed ID: 17378791
[TBL] [Abstract][Full Text] [Related]
2. Comparison of terlipressin and noradrenalin on cerebral perfusion, intracranial pressure and cerebral extracellular concentrations of lactate and pyruvate in patients with acute liver failure in need of inotropic support.
Eefsen M; Dethloff T; Frederiksen HJ; Hauerberg J; Hansen BA; Larsen FS
J Hepatol; 2007 Sep; 47(3):381-6. PubMed ID: 17599633
[TBL] [Abstract][Full Text] [Related]
3. The use of terlipressin in a 14-year-old adolescent with catecholamine-resistant shock after severe traumatic brain injury.
Meyer S; Gottschling S; Gortner L
Acta Anaesthesiol Scand; 2007 Aug; 51(7):957. PubMed ID: 17635407
[No Abstract] [Full Text] [Related]
4. Rescue therapy with terlipressin by continuous infusion in a child with catecholamine-resistant septic shock.
Zeballos G; López-Herce J; Fernández C; Brandstrup KB; Rodríguez-Núñez A
Resuscitation; 2006 Jan; 68(1):151-3. PubMed ID: 16325320
[TBL] [Abstract][Full Text] [Related]
5. Terlipressin as rescue therapy in catecholamine-resistant hypotension in solid organ donors: a case report.
Vecchiarelli P; Ricci F; Riccini T
Transplant Proc; 2010; 42(1):203-5. PubMed ID: 20172313
[TBL] [Abstract][Full Text] [Related]
6. Vasopressin in catecholamine-refractory shock in children.
Meyer S; Gortner L; McGuire W; Baghai A; Gottschling S
Anaesthesia; 2008 Mar; 63(3):228-34. PubMed ID: 18081903
[TBL] [Abstract][Full Text] [Related]
7. Continuous versus bolus infusion of terlipressin in ovine endotoxemia.
Lange M; Morelli A; Ertmer C; Koehler G; Bröking K; Hucklenbruch C; Bone HG; Van Aken H; Traber DL; Westphal M
Shock; 2007 Nov; 28(5):623-9. PubMed ID: 17589382
[TBL] [Abstract][Full Text] [Related]
8. Pilot study to determine the hemodynamic safety and feasibility of magnesium sulfate infusion in children with severe traumatic brain injury.
Natale JE; Guerguerian AM; Joseph JG; McCarter R; Shao C; Slomine B; Christensen J; Johnston MV; Shaffner DH
Pediatr Crit Care Med; 2007 Jan; 8(1):1-9. PubMed ID: 17251875
[TBL] [Abstract][Full Text] [Related]
9. Effects of early and late intravenous norepinephrine infusion on cerebral perfusion, microcirculation, brain-tissue oxygenation, and edema formation in brain-injured rats.
Kroppenstedt SN; Thomale UW; Griebenow M; Sakowitz OW; Schaser KD; Mayr PS; Unterberg AW; Stover JF
Crit Care Med; 2003 Aug; 31(8):2211-21. PubMed ID: 12973182
[TBL] [Abstract][Full Text] [Related]
10. Terlipressin as an adjunct vasopressor in refractory hypotension after tricyclic antidepressant intoxication.
Zuidema X; Dünser MW; Wenzel V; Rozendaal FW; de Jager CP
Resuscitation; 2007 Feb; 72(2):319-23. PubMed ID: 17123689
[TBL] [Abstract][Full Text] [Related]
11. A retrospective analysis of terlipressin in bolus for the management of refractory vasoplegic hypotension after cardiac surgery.
Noto A; Lentini S; Versaci A; Giardina M; Risitano DC; Messina R; David A
Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):588-92. PubMed ID: 19581293
[TBL] [Abstract][Full Text] [Related]
12. Terlipressin infusion in catecholamine-resistant shock.
Jolley DH; De Keulenaer BL; Potter A; Stephens DP
Anaesth Intensive Care; 2003 Oct; 31(5):560-4. PubMed ID: 14601280
[TBL] [Abstract][Full Text] [Related]
13. Terlipressin for catecholamine-resistant septic shock in children.
Rodríguez-Núñez A; Fernández-Sanmartín M; Martinón-Torres F; González-Alonso N; Martinón-Sánchez JM
Intensive Care Med; 2004 Mar; 30(3):477-80. PubMed ID: 14767584
[TBL] [Abstract][Full Text] [Related]
14. Terlipressin in the treatment of late phase catecholamine-resistant septic shock.
Svoboda P; Scheer P; Kantorová I; Doubek J; Dudra J; Radvan M; Radvanova J
Hepatogastroenterology; 2012 Jun; 59(116):1043-7. PubMed ID: 22580654
[TBL] [Abstract][Full Text] [Related]
15. Terlipressin as rescue treatment of refractory shock in a neonate.
Filippi L; Poggi C; Serafini L; Fiorini P
Acta Paediatr; 2008 Apr; 97(4):500-2. PubMed ID: 18307552
[TBL] [Abstract][Full Text] [Related]
16. Continuous terlipressin infusion as rescue treatment in a case series of children with refractory septic shock.
Rodríguez-Núñez A; Oulego-Erroz I; Gil-Antón J; Pérez-Caballero C; López-Herce J; Gaboli M; Milano G;
Ann Pharmacother; 2010 Oct; 44(10):1545-53. PubMed ID: 20841511
[TBL] [Abstract][Full Text] [Related]
17. Terlipressin in brain-death donors.
Piazza O; Scarpati G; Rispoli F; Iannuzzi M; Tufano R; De Robertis E
Clin Transplant; 2012; 26(6):E571-5. PubMed ID: 23121213
[TBL] [Abstract][Full Text] [Related]
18. Terlipressin increased the concentration of L-lactate in the rectal lumen in a patient with septic shock.
Perner A; Jørgensen VL; Waldau T
Acta Anaesthesiol Scand; 2004 Sep; 48(8):1054-7. PubMed ID: 15315626
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology, clinical efficacy and safety of terlipressin in esophageal varices bleeding, septic shock and hepatorenal syndrome.
Saner FH; Canbay A; Gerken G; Broelsch CE
Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):207-17. PubMed ID: 19072411
[TBL] [Abstract][Full Text] [Related]
20. Terlipressin in catecholamine-resistant septic shock patients.
Leone M; Albanèse J; Delmas A; Chaabane W; Garnier F; Martin C
Shock; 2004 Oct; 22(4):314-9. PubMed ID: 15377885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]